We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Announces Guidance on Out-of-Specification Test Results
FDA Announces Guidance on Out-of-Specification Test Results
November 15, 2006
In an effort to help pharmaceutical manufacturers evaluate test results, the FDA is issuing a new guidance on investigating out-of-specification (OOS) results that fall outside the acceptance criteria established in drug applications, drug master files, official compendia or by the manufacturer.
To View This Article:
Login
Subscribe To International Pharmaceutical Regulatory Monitor